Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:42 PM
Ignite Modification Date:
2025-12-24 @ 5:42 PM
NCT ID:
NCT02916368
Eligibility Criteria:
Inclusion Criteria:
* Patients of poor differentiated HNSCC ;
* Patients within the stage of T1-4aN0-2M0;
* The pathological examination of the patients show poor differentiated squamous cell carcinoma;
* Patients with initial treatment(primary, without surgery, radiotherapy and chemotherapy);
* 18-70 years old;
* KPS\>80;
* Hemogram and the function of main organ such as heart, lung, liver and kidney were normal
* Having the endoscopy, CT and MRI Signed the informed consent file, good compliance.
Exclusion Criteria:
* Uncontrollable epileptic seizure, disorder of central nervous system or unconsciousness cause by psychosis;
* Serious and uncontrollable infection;
* Main organ system failure (including heart ,lung ,liver and kidney); reject training;
* High and moderate differentiated squamous cell carcinoma
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT02916368
Study Brief:
Protocol Section:
NCT02916368